Skip to main content
Fig. 2 | Alzheimer's Research & Therapy

Fig. 2

From: Long-term low-dose acetylsalicylic use shows protective potential for the development of both vascular dementia and Alzheimer’s disease in patients with coronary heart disease but not in other individuals from the general population: results from two large cohort studies

Fig. 2

Meta-analysis of the association between low-dose ASA use and dementia outcomes, stratified by age, sex, CHD, and APOE ε4-carrier status. The inverse probability of treatment weighting (IPTW) method was used to obtain hazard ratios. A Alzheimer’s disease. B Vascular dementia. C All-cause dementia

Back to article page

Alzheimer's Research & Therapy

ISSN: 1758-9193